直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Federal Circuit IP Blog

Federal Circuit Clarifies Prosecution History Disclaimer in Design Patents and Reverses Finding of Design Patent and Trademark Infringement

October 27, 2025

Authored and Edited by Prince M. Ene, Pharm. D.; Luke H. MacDonald, Ph.D.; Sonja W. Sahlsten

In Top Brand LLC v. Cozy Comfort Co., No. 2024-2191 (Fed. Cir. July 17, 2025), the Federal Circuit reversed denial of motions for judgment as a matter of law (JMOL) and reversed findings of design patent and trademark infringement.

The parties compete in the oversized hooded sweatshirt and blanket markets. A jury found Top Brand infringed Cozy Comfort’s D859,788 design patent and “THE COMFY” trademark. The jury awarded $15.4 million in disgorged profits for patent infringement and $3.08 million in disgorged profits for trademark infringement.

Top Brand moved for JMOL on both issues, arguing prosecution history disclaimer precluded design patent infringement and no substantial evidence supported trademark infringement. The district court denied those motions, and Top Brand appealed.

First, the Federal Circuit held the “principles of prosecution history disclaimer apply to design patents.” The Court found Cozy Comfort surrendered claim scope by arguing certain features of the claimed hoodie design differed from the prior art. Under this construction, the Court applied the ordinary observer test, i.e., whether an ordinary observer familiar with the prior art would find the overall visual impression of the patented and accused designs substantially similar. The Court found the accused products to be within the disclaimed scope because they contained features similar to the prior art. The Court accordingly reversed denial of JMOL and found no design patent infringement.

Next, the Federal Circuit reversed denial of JMOL on trademark infringement, finding that “THE COMFY” is only entitled to weak protection because it is descriptive or highly suggestive of the goods (blanket throws). The Court also noted that Top Brand did not use the full mark “THE COMFY” but instead used “Comfy” in connection with the accused products.  And the Court found insufficient evidence of actual consumer confusion, finding the proffered evidence—Amazon customer questions and answers—either demonstrated no actual confusion or demonstrated insubstantial evidence of confusion and failed to connect any confusion to Top Brand.

The Federal Circuit accordingly found no trademark infringement.

Tags

damages, Judgment as a Matter of Law (JMOL), patent infringement

Related Practices

Appeals, Issues, and Legal Strategy

Federal Circuit and Supreme Court Appeals

Prosecution and Portfolio Management

Design Rights

Trademark and Brand Management

Trademark Oppositions and Cancellations

Related Industries

Consumer Goods and Services

Consumer Products

Related Offices

Reston, VA

Washington, DC

Contacts

Prince M. Ene, Pharm. D.
Associate
Washington, DC
+1 202 408 4036
Email
Luke H. MacDonald, Ph.D.
Associate
Reston, VA
+1 571 203 2742
Email
Sonja W. Sahlsten
Partner
Washington, DC
+1 202 408 4329
Email

Copyright © 2025 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 

DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Lecture

IPIC/McGill Summer IP Course 2026: Understanding Trademarks

July 14, 2026

Montreal

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Conference

IPBC Global 2026

June 15-17, 2026

San Diego

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

At the PTAB Blog

IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026

May 26, 2026

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Virtual Seminar

Patent "Basics" Seminar

May 19, 2026

Virtual

Conference

19th Annual Forum on Pharma & Biotech Patent Litigation in Europe

May 19-20, 2026

Amsterdam

Webinar

Changes at the PTAB from Settled Expectations to Real Parties in Interest to Director Involvement

May 18, 2026

Webinar

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP